TCLHF(TCLHF)
TCLHF
No analyst ratings available
No analyst price targets available for TCLHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $128.50B | $153.81B | $170.15B |
| Low | $120.33B | $134.33B | $153.49B |
| High | $134.64B | $166.56B | $181.53B |
| EBITDA Avg | $3.89B | $4.66B | $5.15B |
| Low | $3.64B | $4.07B | $4.65B |
| High | $4.08B | $5.04B | $5.50B |
| EBIT Avg | $2.30B | $2.76B | $3.05B |
| Low | $2.16B | $2.41B | $2.75B |
| High | $2.41B | $2.98B | $3.25B |
| Net Income Avg | $3.06B | $3.82B | $4.58B |
| Low | $2.67B | $3.34B | $3.99B |
| High | $3.32B | $4.16B | $4.97B |
| EPS Avg | $1.20 | $1.51 | $1.80 |
| Low | $1.05 | $1.31 | $1.57 |
| High | $1.31 | $1.64 | $1.96 |
| Analysts (Rev / EPS) | 7 / 1 | 8 / 1 | 6 / 1 |
| Metric | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|
| Revenue Avg | $48.96B | $48.96B | $48.96B | $48.96B | $66.86B |
| Low | $48.96B | $48.96B | $48.96B | $48.96B | $66.86B |
| High | $48.96B | $48.96B | $48.96B | $48.96B | $66.86B |
| EBITDA Avg | $1.48B | $1.48B | $1.48B | $1.48B | $2.02B |
| Low | $1.48B | $1.48B | $1.48B | $1.48B | $2.02B |
| High | $1.48B | $1.48B | $1.48B | $1.48B | $2.02B |
| EBIT Avg | $877M | $877M | $877M | $877M | $1.20B |
| Low | $877M | $877M | $877M | $877M | $1.20B |
| High | $877M | $877M | $877M | $877M | $1.20B |
| Net Income Avg | — | — | — | — | $1.50B |
| Low | — | — | — | — | $1.50B |
| High | — | — | — | — | $1.50B |
| EPS Avg | — | — | — | — | $0.59 |
| Low | — | — | — | — | $0.59 |
| High | — | — | — | — | $0.59 |
| Analysts (Rev / EPS) | 1 / — | 1 / — | 1 / — | 1 / — | 1 / 1 |